Join our keynote speaker, Deepta Bhattacharya, as he shares about guiding curative treatments for type 1 diabetes past the immune system.
Deepta Bhattacharya, PhD, is the inaugural executive director of the Center for Advanced Molecular and Immunological Therapies and a professor in the University of Arizona College of Medicine – Tucson Department of Immunobiology.
Bhattacharya’s research merges the fields of stem cell biology and immunology to develop creative translational strategies for regenerative medicine. Bhattacharya was a recipient of the prestigious New York Stem Cell Foundation Robertson Investigator award in 2012. Bhattacharya’s research has contributed to translational efforts at companies including Gilead Sciences, Sana Biotechnology, Clade Therapeutics and Jasper Therapeutics.
Bhattacharya received his bachelor’s in biochemistry from Indiana University and his doctorate in molecular and cell biology from the University of California, Berkeley. For his postdoctoral fellowship he trained at Stanford University. In 2008, he began his own lab at Washington University in St. Louis where he rose through the ranks before returning in 2017 to his birthplace of Arizona to join the Department of Immunobiology, where his lab continues to study both transplantation immunology of stem cells and antibody responses to infections and vaccines.
